Both in Pharmaceuticals
Atea Pharmaceuticals vs ARS Pharmaceuticals
Over the past year AVIR returned +26.5% and SPRY returned −60.8%; their daily moves had a correlation of 0.27.
AVIR +26.5% SPRY −60.8%Growth of $1, one year, split-adjusted
| Metric | AVIR | SPRY |
|---|---|---|
| Price | $4.11 | $3.38 |
| Market cap | $329.6M | $336.1M |
| Today | −4.64% | −7.65% |
| 1 month | −19.4% | −18.0% |
| 6 months | −26.3% | −60.5% |
| Year to date | +15.1% | −71.0% |
| 1 year | +24.9% | −62.4% |
| Revenue growth (YoY) | — | +114.2% |
| Gross margin | — | 61.8% |
| Net margin | — | −185.2% |
| P/E (TTM) | — | — |
| Price / sales | — | 2.9× |
| Net cash | $219.5M | -$27.8M |
| Dividend yield | — | — |
| Volatility (60d) | 46.4% | 71.5% |
| Short % of float | 5.0% | 40.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).